To assess the role of JNK2 in expression of Sp1 and MMP‐2, as well as cancer cell invasion, T24T cells were transfected with the shRNA specifically targeting jnk2, and the knockdown transfection efficiency was analyzed (Fig. 5D). This evidence concerns the gene MAPK9 and cancer.